Biopharmaceutical company Stemline Therapeutics Inc. (STML) is currently trading at $12.02, up $7.27 or 153.05% in the pre-market session. The stock has been trading between $3.21 and $18.22 in the past one year, and closed Friday's trade at $4.75, down 62 cents or 11.55%. STML
from RTT - Before the Bell https://ift.tt/3bXleIF
via IFTTT
No comments:
Post a Comment